Unilever Values Beauty, Supplement Sectors As It Considers Leaving Others
Unilever reported 0.5% full-year sales growth for the beauty and personal care division to €5.6bn and overall growth was 2.9% to €52bn, but the fourth quarter was its weakest in more than a decade, with reported sales growth at 1.5% to €12.6bn.
You may also be interested in...
Unilever acquires ‘modern, prestige’ skin care firm Tatcha in a reported $500m deal. Tatcha's comprises dozens of items formulated with green tea, rice and algae. Unilever continues seeking beauty and personal care deals, which accounted for 70% of its acquired turnover in recent years.
Firm's Hindustan Unilever division will merge with s GSK Consumer Healthcare India which has had total sales around €550m so far in 2018, primarily through the Horlicks and Boost brands and with nearly 90% of the revenues in India. Also will acquire 82% stake in GSK Bangladesh and other GSK commercial operations and assets outside India, paying €3.3bn in combination of cash and shares in Hindustan Unilever.
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.